We are live on ! Find out more
BMO

Beck Mack & Oliver Portfolio holdings

AUM $4.85B
1-Year Est. Return 9.66%
This Fund
S&P 500
This Quarter Est. Return
+8.44%
1 Year Est. Return
+9.66%
3 Year Est. Return
+69.39%
5 Year Est. Return
+96.17%
10 Year Est. Return
+350.87%
AUM
$3.15B
AUM Growth
+$171M
Cap. Flow
-$50.7M
Cap. Flow %
-1.61%
Top 10 Hldgs %
39.38%
Holding
234
New
3
Increased
16
Reduced
102
Closed
4

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$69.5M
2
APO icon
Apollo Global Management
APO
+$21.5M
3
BB icon
BlackBerry
BB
+$7.83M
4
LUMN icon
Lumen
LUMN
+$5.06M
5
OAK
OAKTREE CAPITAL GROUP, LLC
OAK
+$1.86M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$20.2M
2
JEF icon
Jefferies Financial Group
JEF
+$15.3M
3
BAX icon
Baxter International
BAX
+$13.3M
4
LBTYA icon
Liberty Global Class A
LBTYA
+$12.6M
5
ABT icon
Abbott
ABT
+$6.71M

Sector Composition

Rank Sector Weight
1 Financials 29.01%
2 Healthcare 16.47%
3 Technology 12.09%
4 Communication Services 10.94%
5 Energy 10.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DOV icon
26
Dover
DOV
$26.7B
$41.8M 1.33%
472,530
-51,003
-10% -$4.21M
UNP icon
27
Union Pacific
UNP
$174B
$41M 1.3%
251,807
-8,760
-3% -$1.32M
AXP icon
28
American Express
AXP
$224B
$38.2M 1.21%
358,439
-750
-0.2% -$78K
BB icon
29
BlackBerry
BB
$4.58B
$37.3M 1.18%
3,275,529
+766,300
+31% +$7.83M
BN icon
30
Brookfield
BN
$102B
$33.1M 1.05%
2,085,569
-149,154
-7% -$2.27M
GILD icon
31
Gilead Sciences
GILD
$165B
$31.1M 0.99%
402,492
+6,876
+2% +$519K
MDR
32
DELISTED
McDermott International
MDR
$30.5M 0.97%
1,657,417
-154,525
-9% -$2.89M
LOW icon
33
Lowe's Companies
LOW
$121B
$30.3M 0.96%
263,727
-18,753
-7% -$1.95M
DISCK
34
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$27.6M 0.88%
931,801
+43,875
+5% +$1.14M
GRFS
35
Grifois
GRFS
$5.55B
$27.1M 0.86%
1,266,743
-245,448
-16% -$5.18M
LBTYA icon
36
Liberty Global Class A
LBTYA
$3.59B
$25.5M 0.81%
880,045
-452,558
-34% -$12.6M
JEF icon
37
Jefferies Financial Group
JEF
$12.7B
$24.5M 0.78%
1,244,825
-734,281
-37% -$15.3M
FDX icon
38
FedEx
FDX
$73B
$22.8M 0.72%
94,498
-1,490
-2% -$361K
VZ icon
39
Verizon
VZ
$197B
$21.2M 0.67%
397,228
-25,492
-6% -$1.35M
XOM icon
40
ExxonMobil
XOM
$650B
$20M 0.64%
235,789
-9,009
-4% -$737K
USB icon
41
US Bancorp
USB
$97.9B
$19.2M 0.61%
364,251
-39,579
-10% -$2.1M
SYY icon
42
Sysco
SYY
$40.8B
$18.9M 0.6%
257,342
-12,557
-5% -$905K
MRK icon
43
Merck
MRK
$322B
$17.6M 0.56%
260,029
-317,688
-55% -$20.2M
ENB icon
44
Enbridge
ENB
$120B
$16.8M 0.53%
521,359
-47,909
-8% -$1.67M
WMB icon
45
Williams Companies
WMB
$85.8B
$15.3M 0.48%
560,861
-45,558
-8% -$1.32M
WMT icon
46
Walmart Inc
WMT
$909B
$15M 0.48%
480,336
-14,505
-3% -$444K
DUK icon
47
Duke Energy
DUK
$101B
$15M 0.48%
187,776
-12,997
-6% -$1.05M
NTR icon
48
Nutrien
NTR
$33.9B
$13.4M 0.42%
231,634
-20,880
-8% -$1.16M
RDS.A
49
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$11.8M 0.38%
173,617
-9,925
-5% -$663K
HUBB icon
50
Hubbell
HUBB
$24.4B
$11.7M 0.37%
87,906
-1,475
-2% -$181K
1
2
3 4 5

Similar funds

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
MCCA
Mill Creek Capital Advisors Conshohocken, Pennsylvania $4.87B AUM 17.69% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $4.82B AUM 15.21% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
JSTA
Japan Science & Technology Agency Tokyo, Japan $4.81B AUM 4.62% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
KCM
Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return

Beck Mack & Oliver's Q3 2018 Portfolio in Review

As of Q3 2018, Beck Mack & Oliver held 234 positions worth $3.15B, up 5.7% from $2.98B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Trading was light in Q3 2018: portfolio turnover was 3%. Beck Mack & Oliver opened 3 new positions and exited 4, leaving the 234-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Technology.

  • Beck Mack & Oliver's largest Q3 2018 buy was Teva Pharmaceuticals: 2,993,705 shares worth $64.5M.
  • Beck Mack & Oliver added most to Apollo Global Management in Q3 2018, an estimated $21.5M increase.
  • Beck Mack & Oliver's biggest Q3 2018 reduction was Merck, cutting an estimated $20.2M.
  • Beck Mack & Oliver fully exited JPMorgan Chase & Co. Depositary Shares, each representing a 1/400th interest in a share of 6.10% Non in Q3 2018, selling an estimated $211K.
  • Beck Mack & Oliver's ten largest holdings make up 39% of its $3.15B portfolio in Q3 2018.
  • Beck Mack & Oliver opened 3 new positions and closed 4 in Q3 2018.
  • Beck Mack & Oliver's portfolio value rose 5.7% quarter-over-quarter to $3.15B.

Based on Beck Mack & Oliver's 13F filing for Q3 2018, filed 29 Oct 2018.